뉴스
- Genome & Company·LabGenomics Rally in Korea Stock Market[K-BIO PULSE] South Korean pharmaceutical, biotech and healthcare stocks staged a broad-based rally on June 9, as sector-specific catalysts drove sharp gains in select names
- Korean Investors' U.S. Stock Holdings Reclaim $200 Billion domestic stock market. According to data from SEIBRO, the securities information portal of the...
- 반도체 ETF(SOXL) 결제 1위…나스닥100·S&P500 순매수 강세 A 3x leveraged ETF linked to the South Korean stock market and a 2x leveraged ETF linked to Tesla also
- Rising Rates Push Securities Firms' Bond Valuation Gains into the Red, Cl... A cloud is gathering over securities firms that had benefited from the stock market rally.
- Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse] On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations The tech-heavy Kosdaq market...
- Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse] On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies
- Will Investment Sentiment Return to Bio Amid Tech Adjustment? KM Pharmaceutical and Lemon Healthc... As the domestic stock market recently enters a breathing spell focused on semiconductors and key Information
- Inverse ETFs Dominate Bear Market [K-Bio Pulse] On July 29, South Korea’s domestic stock market experienced continued weakness, leading inverse
- Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ... South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
- Chasing High Returns Despite Risks? Three "Problematic" Bio Stocks Land Among Top 15 Ga... As the domestic stock market enters a correction phase, loose liquidity is flowing back into the pharmaceutical
1 페이지
다음 →